FormWeb • pramipexole

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

pramipexole

pramipexole

Formulary Miscellaneous Program Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Mirapex ER	TABLET, EXTENDED RELEASE, ORAL	0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg
Mirapex	TABLET, ORAL	0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg

VIEW MORE Central Nervous System Agents, Miscellaneous

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

pramipexole (Mirapex ER)

0.375 mg extended release oral tablet daily
0.75 mg extended release oral tablet daily
1.5 mg extended release oral tablet daily
3 mg extended release oral tablet daily
4.5 mg extended release oral tablet daily

pramipexole (Mirapex)

0.125 mg tablet oral TID
0.25 mg tablet oral TID
0.5 mg tablet oral TID
1 mg tablet oral TID
1.5 mg tablet oral TID

Interchange Mirapex ER to regular release pramipexole tablets given TID, at the same total daily dosage.

Reviewed: May 25, 2010 (Mirapex ER)

Last updated: Dec. 26, 2017

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.